These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2255925)

  • 1. Neuroleptic malignant syndrome in organic brain disease and physical illness.
    Pilo L
    Singapore Med J; 1990 Aug; 31(4):311-3. PubMed ID: 2255925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluphenazine-induced neuroleptic malignant syndrome in a schizophrenic patient.
    Aruna AS; Murungi JH
    Ann Pharmacother; 2005 Jun; 39(6):1131-5. PubMed ID: 15840734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuroleptic malignant syndrome. Case reports].
    Berardi D; Troia M; Veronesi L; Ferrari G
    Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An unusual presentation of neuroleptic malignant syndrome.
    Basu J
    J Indian Med Assoc; 1991 Jan; 89(1):16. PubMed ID: 2051035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potentially aborted neuroleptic malignant syndrome following seclusion against uncontrollable water intoxication.
    Suzuki T; Uchida H; Watanabe K; Kashima H
    Psychopharmacol Bull; 2008; 41(1):164-70. PubMed ID: 18362879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome and mental retardation: review and analysis of 29 cases.
    Boyd RD
    Am J Ment Retard; 1993 Jul; 98(1):143-55. PubMed ID: 8103996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuroleptic malignant syndrome: a neurologic pathology of great interest for the internist].
    Blasi C; D'Amore F; Levati M; Bandinelli MC
    Ann Ital Med Int; 1998; 13(2):111-6. PubMed ID: 9734143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinico-therapeutic observations in the neuroleptic malignant syndrome].
    Grecu G; Grecu-Gaboş M; Nireşteanu A; Grecu-Gaboş I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1989; 34(4):267-76. PubMed ID: 2577227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroleptic malignant syndrome: a review of literature].
    Crespo Facorro B; Carbonell Masia C
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(5):273-8. PubMed ID: 8553925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic malignant syndrome--a study of 4 cases.
    Maniam T; Jamaluddin J; Kyaw O
    Singapore Med J; 1988 Jun; 29(3):293-5. PubMed ID: 3187583
    [No Abstract]   [Full Text] [Related]  

  • 12. Atypical (olanzapine) plus conventional (fluphenazine) neuroleptic treatment associated with the neuroleptic malignant syndrome.
    Tofler IT; Ahmed B
    J Clin Psychopharmacol; 2003 Dec; 23(6):672-4. PubMed ID: 14624203
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome.
    Bristow MF; Kohen D
    Br J Hosp Med; 1996 Apr 17-30; 55(8):517-20. PubMed ID: 8732227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuroleptic malignant syndrome after aortic valve replacement; report of a case].
    Ichiba T; Takemoto N
    Kyobu Geka; 2003 Sep; 56(10):872-4. PubMed ID: 13677924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuroleptic malignant syndrome].
    Johannessen JO; Bergrem H
    Tidsskr Nor Laegeforen; 1989 Feb; 109(6):696-7. PubMed ID: 2922736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuroleptic malignant syndrome (dopamine-dependent malignant hyperthermia). 4 different cases].
    Truong DD; Sczesni B; Fahn S; Gross J; Donovan K; van Bakel A; Wiley MK
    Nervenarzt; 1988 Feb; 59(2):103-9. PubMed ID: 2896306
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neuroleptic malignant syndrome, multiorgan failure and peripheral polyneuropathy].
    Mesejo A; Núñez C; Simó M; Blanquer J; Pérez PL; Ruiz F; Cuñat J
    Rev Neurol; 1995; 23(119):136-8. PubMed ID: 8548608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for the neuroleptic malignant syndrome.
    Kirkpatrick B; Edelsohn GA
    Psychiatr Med; 1984 Dec; 2(4):371-81. PubMed ID: 6152857
    [No Abstract]   [Full Text] [Related]  

  • 19. Shared features of neuroleptic malignant syndrome and alcohol abuse complications.
    Krystal AD; McEvoy JP
    J Clin Psychiatry; 1990 Dec; 51(12):523. PubMed ID: 2258367
    [No Abstract]   [Full Text] [Related]  

  • 20. [Neuroleptic malignant syndrome in the elderly: description of 4 patients].
    Cruz JM; Pato M; Gómez XA; Batalla A; Cutrin C
    An Med Interna; 1997 Aug; 14(8):415-8. PubMed ID: 9376483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.